Inspiration meets innovation at Brandweek, the ultimate marketing experience. Join industry luminaries, rising talent and strategic experts in Phoenix, Arizona this September 23–26 to assess challenges, develop solutions and create new pathways for growth. Register early to save.
Omnicom agencies BBDO New York and The CDM Group have been given U.S. creative lead responsibilities for Bristol-Myers Squibb’s Abilify antidepressant drug, sources said.
The brand, which had been at Digitas Health, spent $133.7 million in U.S. measured media last year according to Nielsen. That amount does not include internet spending or business-to-business marketing.
The CDM Group, formerly known as Cline Davis & Mann, and BBDO either did not respond to inquiries or referred calls to BMS.
WORK SMARTER - LEARN, GROW AND BE INSPIRED.
Subscribe today!
To Read the Full Story Become an Adweek+ Subscriber
Already a member? Sign in